Surgical Science Sweden AB Stock price
Equities
SUS
SE0014428512
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
150.3 SEK | -1.38% | +2.04% | -17.97% |
Mar. 12 | Surgical Science Sweden to Step Down; Search for Successor Starts | MT |
Mar. 12 | Gisli Hennermark Intends to Leave as CEO of Surgical Science Sweden AB | CI |
Sales 2023 | 883M 82.56M | Sales 2024 * | 1.01B 94.04M | Capitalization | 7.78B 727M |
---|---|---|---|---|---|
Net income 2023 | 234M 21.88M | Net income 2024 * | 216M 20.2M | EV / Sales 2023 | 10.5 x |
Net cash position 2023 * | 609M 56.92M | Net cash position 2024 * | 863M 80.69M | EV / Sales 2024 * | 6.88 x |
P/E ratio 2023 |
39.8
x | P/E ratio 2024 * |
36
x | Employees | 260 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 72.91% |
Latest transcript on Surgical Science Sweden AB
1 day | -1.97% | ||
1 week | +1.84% | ||
Current month | +0.07% | ||
1 month | -3.98% | ||
3 months | -20.91% | ||
6 months | +3.89% | ||
Current year | -18.14% |
Managers | Title | Age | Since |
---|---|---|---|
Anders Larsson
FOU | Founder | 51 | 97-07-23 |
Gisli Hennermark
CEO | Chief Executive Officer | 52 | 14-12-31 |
Director of Finance/CFO | 54 | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roland Bengtsson
CHM | Chairman | 69 | 04-12-31 |
Director/Board Member | 57 | 16-12-31 | |
Director/Board Member | 49 | 21-05-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 5 M€ | +13.27% | ||
0.00% | 10 M€ | -3.35% | - | |
0.00% | 150 M€ | -1.24% | - | |
0.00% | 26 M€ | -2.02% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 150.3 | -1.38% | 59 073 |
24-03-27 | 152.4 | +2.70% | 109,448 |
24-03-26 | 148.4 | +1.64% | 35,777 |
24-03-25 | 146 | -0.34% | 51,785 |
24-03-22 | 146.5 | -0.14% | 573,396 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 05:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.14% | 732M | |
+21.23% | 37.65B | |
+8.26% | 6.99B | |
+13.78% | 3.74B | |
-0.91% | 3.73B | |
-27.35% | 1.27B | |
-22.30% | 1.34B | |
-32.52% | 944M | |
-25.64% | 846M | |
-7.60% | 826M |